Genetic Analysis AS (NGM:GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK 1.030
-0.020 (-1.90%)
At close: Jun 12, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 48.27 million as of June 13, 2025. Its market cap has increased by 89.19% in one year.
Market Cap
48.27M
Enterprise Value
45.55M
Revenue
19.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.03
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 48.27M, a decrease of -79.50%. That is a compound annual growth rate of -34.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 48.27M | 97.33% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 97.89B |
| Sectra AB | 60.46B |
| Getinge AB | 51.14B |
| Asker Healthcare Group AB | 41.61B |
| Medicover AB | 36.46B |
| Camurus AB | 35.89B |
| AddLife AB | 23.97B |
| Vimian Group AB | 21.81B |